| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics Inc. | Director | Common Stock | 32,057,147 | $600,750,934 | $18.74 | 21 Oct 2025 | Akeso, Inc. |
| Summit Therapeutics Inc. | Director | Stock Option (right to buy) | 35,000 | $49,921 | $9.18 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 18:52 |
| SMMT | Summit Therapeutics Inc. | 21 Oct 2025 | 1 | +$9,999,983 | 4 | Director | 23 Oct 2025, 21:06 |
| SMMT | Summit Therapeutics Inc. | 02 Jan 2025 | 2 | +$49,921 | 4 | Director | 06 Jan 2025, 19:24 |
| SMMT | Summit Therapeutics Inc. | 02 Jan 2024 | 2 | $0 | 4 | Director | 04 Jan 2024, 16:19 |
| SMMT | Summit Therapeutics Inc. | 31 Dec 2023 | 2 | +$47,699,706 | 5 | Director | 14 Feb 2024, 16:35 |
| SMMT | Summit Therapeutics Inc. | 17 Jan 2023 | 0 | $0 | 3 | Director | 26 Jan 2023, 13:48 |